Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent

Details for Australian Patent Application No. 2007201753 (hide)

Owner Osprey Pharmaceuticals USA, Inc.

Inventors Coggins, Philip J; McDonald, John R

Agent Spruson & Ferguson

Pub. Number AU-B-2007201753

Parent 2007200061

Filing date 19 April 2007

Wipo publication date 10 May 2007

Acceptance publication date 27 November 2008

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/19 (2006.01) Mutation or genetic engineering - Interferons

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

10 May 2007 Application Open to Public Inspection

  Published as AU-B-2007201753

10 May 2007 Complete Application Filed

21 August 2008 Assignment before Grant

  Osprey Pharmaceuticals Limited The application has been assigned to Osprey Pharmaceuticals USA, Inc.

27 November 2008 Application Accepted

  Published as AU-B-2007201753

26 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201754-Method and Apparatus for Extending Battery Life by Adaptive Control of Regulators

2007201752-Method of setting the storey associations of a plurality of operating units of a lift installation